Nectero Medical Funding: $116M Raised, Series D (2024)
Nectero Medical is a Biotech company based in Bethlehem. It has raised $116M in total funding. Latest round: Series D.
Nectero Medical funding overview
Nectero Medical is a Biotech company based in Bethlehem. Nectero Medical has raised $116M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in April 2024. The round record for Nectero Medical runs through 2024; nothing later has been disclosed. Investors on record include Norwest Venture Partners, Boston Scientific, BioStar Capital, Aphelion Capital. 4 distinct backers are named across the disclosed rounds.
Nectero Medical at a glance
Total raised
$116M
Latest round
Series D
Latest round date
April 2024
Industry
Biotech
Headquarters
Bethlehem
Notable investors
Norwest Venture Partners, Boston Scientific, BioStar Capital, Aphelion Capital
Frequently asked about Nectero Medical funding
How much has Nectero Medical raised?
Nectero Medical has raised $116M in total disclosed funding across the rounds on record.
Who has invested in Nectero Medical?
Norwest Venture Partners, Boston Scientific, BioStar Capital, Aphelion Capital are named among the investors backing Nectero Medical.
What was the latest Nectero Medical funding round?
The most recent disclosed round is a Series D, announced in April 2024.
Where is Nectero Medical based?
Nectero Medical is based in Bethlehem.
What sector does Nectero Medical operate in?
Nectero Medical is tracked under Biotech from Bethlehem, with $116M in disclosed funding.
When did Nectero Medical last raise?
The last disclosed Nectero Medical round closed in April 2024 at Series D.
We update the Nectero Medical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Bethlehem and their backers are listed below.
